ARCHIVES

Two former Bristol-Myers Squibb executives were indicted as the company agreed to pay $300 million to investors.

This article is from The Cancer Letter archive.

Vol. 31 No. 24 | June 17, 2005

Download PDF Visit The Full Archive

Related Articles

Study Finds That CTC Was Used Correctly In Medicare Patients

April 26, 2013

In Brief: DeVita wins $150,000 Pezcoller Prize; BreastPac To “Storm” Capitol On Bastille Day For More $$

July 8, 1988

RAS Mutations Can Predict Resistance To Vectibix, FOLFOX Combination Treatment

September 27, 2013

In Brief: NCI Names Rice To Head Frederick Center; NIAID Appoints Killen DAIDS Director

April 22, 1994

NCI Cooperative Group Clinical Trials Approved

August 28, 2009

Obituary: Joan Mauer, 65, Chief, NCI Clinical Trials Monitoring Branch

October 15, 2010